Diagnostic insights to identify and manage breast cancer
About 1 in 3 people in the United States will develop cancer during their lifetime1, so it’s not uncommon to have many cancers in the same family. Less often, cancers in a family are strongly linked to an inherited gene mutation that is part of a hereditary cancer syndrome. Individuals who have a mutation in a cancer predisposition gene have a higher risk for developing certain types of cancer.
Screening
Hereditary Breast Cancer Panel
The Hereditary Breast Cancer Panel includes 16 genes associated primarily with hereditary breast—and possibly other—cancers. This can include, but is not limited to, cancers of the breast, colon, endometrium, stomach, urinary tract, ovary, pancreas, prostate, and other tissues. Individuals with a positive result (pathogenic or likely pathogenic variant detected) have an increased risk for developing certain cancers relative to that of the general population.
BRCA
Cancer can be more common in some families than others. Quest Diagnostics BRCA Panel Plus tests for genes predominantly associated with breast cancer, including BRCA1 and BRCA2. These tests are available for adults of all ages, but it’s best to talk with your doctor or genetic counselor to decide if genetic testing is right for you. Getting tested can also give important information to your family that can help family members understand their risk for cancer.
Diagnosis
The AmeriPath® national network of board-certified pathologists provides comprehensive pathology services utilizing state-of-the-art technologies including immunohistochemistry and molecular diagnostics.
We are an industry leader in breast tumor pathology expertise. Combined with our comprehensive test menu and advanced technology, our expertise ensures you receive accurate diagnostic, prognostic, and therapeutic information promptly.
Learn more at AmeriPath®: Anatomic Pathology Services.
Prognosis
Prosigna
The Prosigna® Breast Cancer Gene Signature Assay is a prognostic indicator for distant recurrence-free survival at 10 years in postmenopausal women. Prosigna should be used in conjunction with other clinicopathological factors.
Breast Cancer Tests
This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.
References
- American Cancer Society. Family cancer syndromes. Updated August 5, 2020. Accessed August 10, 2020. https://www.cancer.org/cancer/cancer-causes/genetics/family-cancer-syndromes.html
During the COVID-19 health crisis, fast action and trusted information matter more than ever.
Find out what's happening
Types of cancer
Cancer
-
Breast -
Cervical -
test -
GI, Colorectal -
Leukemia -
Lung -
Lymphoma -
Melanoma -
Myeloma -
MPN -
Ovarian -
Prostate -
Thyroid -
Pan-cancer -
Hereditary cancer -
Comprehensive and guideline-based hereditary cancer panels -
Targeted panels for hereditary cancers -
Additional hereditary cancer risk tests -
Targeted single-gene and single site tests -
Experts and insights -
Understanding results -
Financial support -
EHR and ordering -
Variant Investigation -
Hereditary cancer genetic testing menu -
Skin Cancers -
Hematology -
Solid Tumor -
Quest Pap Smear for the Pancreas -
Q3 CS -
Oncology -
Haystack MRD
Questions about oncology testing?
Quest offers its clients a dedicated oncology customer support line to assist with any test-related questions.
Contact our dedicated customer service team at: 1.833.773.1441
Know more so you can do more for your patients
The Quest Hereditary Cancer Screening test portfolio offers you and your patients insights into hereditary risk so you can make more informed decisions together.
- Site map
- Privacy Notices
- Terms
- Contact us
- Language assistance / non-discrimination
- Asistencia de idiomas / Aviso de no discriminación
- 語言協助 / 不歧視通知
- Accessibility
-
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.